S. Khagi

发表

Personalized‐induced neural stem cell therapy: Generation, transplant, and safety in a large animal model

Kevin T. Sheets, Hunter N. Bomba, D. Tokarz, 2020, Bioengineering & translational medicine.

Tumoricidal Stem Cell Therapy Enables Killing in Novel Hybrid Models of Heterogeneous Glioblastoma.

D. Lo, S. Hingtgen, Denise E. Dunn, 2019, Neuro-oncology.

Use of FLOSEAL® as a scaffold and its impact on induced neural stem cell phenotype, persistence, and efficacy

Kevin T. Sheets, Hunter N. Bomba, Morgan J Goetz, 2021, Bioengineering & translational medicine.

Pancreatic neuroendocrine tumors: targeting the molecular basis of disease

M. Saif, S. Khagi, 2015, Current opinion in oncology.

Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement.

Susan M. Chang, M. Mehta, P. Wen, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

Neuroendocrine tumors: treatment updates.

M. Saif, S. Khagi, 2013, JOP : Journal of the pancreas.

Neuroendocrine Tumors : Treatment Updates Highlights from the “ 2013 ASCO Annual Meeting ” . Chicago , IL , USA ; May 30-June 4 , 2013

M. Saif, S. Khagi, 2013 .

Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma

F. Ligler, B. Savoldo, G. Dotti, 2021, Science advances.

Response to Selpercatinib in a Patient With Recurrent Glioblastoma and RET Amplification.

S. Khagi, C. Zamora, Ashley Chen, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Steven R. Abram, T. Mikkelsen, S. Toms, 2022, JAMA oncology.

Pancreatic neuroendocrine tumor with ectopic adrenocorticotropin production: a case report and review of literature.

M. Saif, R. Lechan, F. Patel, 2013, Anticancer research.

Hemophagocytic syndrome in a patient with human immunodeficiency virus, Epstein-Barr viremia, and newly diagnosed Hodgkin lymphoma.

S. Khagi, O. Danilova, C. Rauwerdink, 2012, Clinical advances in hematology & oncology : H&O.

Clinical Application of Next-Generation Sequencing in Recurrent Glioblastoma

N. Rashid, S. McCabe, K. Pietrosimone, 2021, Onco.

Immunotherapy Clinical Trials in Neuro-Oncology

G. Vlahović, S. Khagi, 2017 .

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Steven R. Abram, T. Mikkelsen, S. Toms, 2018, Journal of Translational Medicine.

Neurologic Complications

S. Khagi, M. R. Gilbert, S. Yust-Katz, 2020, Abeloff's Clinical Oncology.

Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome

S. Khagi, Katherine P. Morgan, Danielle M. File, 2020, JCO precision oncology.

Systematic review of combinations of targeted or immunotherapy in advanced solid tumors

Susan M. Chang, M. Mehta, P. Wen, 2021, Journal for ImmunoTherapy of Cancer.

Hemophagocytic lymphohistiocytosis in a patient with glioblastoma: a case report

Vaibhav Kumar, S. Khagi, Patrick J. Eulitt, 2019, CNS oncology.

A Head Start: CAR-T Cell Therapy for Primary Malignant Brain Tumors

S. Khagi, Nicholas P. Tschernia, 2020, Current Treatment Options in Oncology.

Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients.

C. Miller, M. Ewend, J. Bago, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Tumor-homing Stem Cell Therapy for Brain Cancer

Vivien Lettry, S. Hingtgen, S. Khagi, 2017, Current Surgery Reports.

Next-generation sequencing reveals novel mutations in a collision tumor of glioblastoma and meningioma

S. Khagi, Katherine Saunders, Gregory Chamberlin, 2021, CNS oncology.

LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)

T. Cloughesy, H. Colman, M. Daras, 2020 .

Antiangiogenic virotherapy: VB-111 targeting glioma

K. Peters, S. Khagi, 2016 .

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Steven R. Abram, T. Mikkelsen, S. Toms, 2018, Journal of Translational Medicine.

The management of gastroenteropancreatic neuroendocrine tumors with somatostatin analogues.

M. Saif, S. Khagi, 2014, JOP : Journal of the pancreas.

Gastroenteropancreatic neuroendocrine tumors: hormonal treatment updates.

M. Saif, S. Khagi, 2014, JOP : Journal of the pancreas.

LTBK-01. INO-5401 AND INO-9012 DELIVERED INTRAMUSCULARLY (IM) WITH ELECTROPORATION (EP) IN COMBINATION WITH CEMIPLIMAB (REGN2810) IN NEWLY DIAGNOSED GLIOBLASTOMA

F. Lieberman, D. Weiner, S. Brem, 2020 .

ATIM-33. INTERIM RESULTS OF A PHASE II MULTI-CENTER STUDY OF ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)

T. Cloughesy, H. Colman, M. Daras, 2019, Neuro-Oncology.

Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

Takafumi N. Yamaguchi, R. Stupp, W. Mason, 2023, Nature Network Boston.

Intramuscular (IM) INO-5401 + INO-9012 with electroporation (EP) in combination with cemiplimab (REGN2810) in newly diagnosed glioblastoma.

F. Lieberman, S. Brem, I. Lowy, 2022, Journal of Clinical Oncology.